companydata.dkBioMed Invest ApS: Financial statements 2024
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 21,365 and a net result of DKK 451,303 compared with DKK 617,481 the year before. That is a decrease of 5.3% compared with the year before. Equity amounted to DKK 8,820,487. The solvency ratio was 98%. The company had 2 employees in the financial year.
- Gross Profit
- 21,365 kr.
- Profit/Loss
- 451,303 kr.
- Equity
- 8,820,487 kr.
- Total Assets
- 9,003,412 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 21 t. | 451 t. | 8.8 mio. | 2 |
| 2023 | - | 23 t. | 617 t. | 8.4 mio. | 2 |
| 2022 | - | 21 t. | -878 t. | 7.8 mio. | 2 |
| 2021 | - | 246 | 7.3 mio. | 8.6 mio. | 1 |
| 2020 | - | 28 t. | 6 t. | 1.4 mio. | - |
How creditworthy is BioMed Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
BioMed Invest ApS has published its annual report for 2023. Gross profit came to DKK 22,558, and the net result was DKK 617,481.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.